Sanofi moves for reconsideration in US antitrust case over injectable insulin
MLex Summary: Sanofi-Aventis asked a US federal judge to reconsider whether Mylan can plead a bundled-discount theory of exclusion based on a bundle of products in the same product market, in...To view the full article, register now.
Already a subscriber? Click here to view full article